N-Acetylcysteine in the Treatment of Acute Lung Injury: Perspectives and Limitations
International Journal of Molecular Sciences · 15.03.2025 · 26 (6) · 2657
DOI: 10.3390/ijms26062657 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.03.2025. Verfasst von Daniela Mokra und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, SK-03601 Martin, Slovakia. Hauptthemen laut MEDLINE: Acetylcysteine, Acute Lung Injury. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Slovak Research and Development Agency, Ministry of Education, Science, Research and Sport of the Slovak Republic.
Abstract (Originalsprache)
N-acetylcysteine (NAC) can take part in the treatment of chronic respiratory diseases because of the potent mucolytic, antioxidant, and anti-inflammatory effects of NAC. However, less is known about its use in the treatment of acute lung injury. Nowadays, an increasing number of studies indicates that early administration of NAC may reduce markers of oxidative stress and alleviate inflammation in animal models of acute lung injury (ALI) and in patients suffering from distinct forms of acute respiratory distress syndrome (ARDS) or pulmonary infections including community-acquired pneumonia or Coronavirus Disease (COVID)-19. Besides low costs, easy accessibility, low toxicity, and rare side effects, NAC can also be combined with other drugs. This article provides a review of knowledge on the mechanisms of inflammation and oxidative stress in various forms of ALI/ARDS and critically discusses experience with the use of NAC in these disorders. For preparing the review, articles published in the English language from the PubMed database were used.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, SK-03601 Martin, Slovakia.
- Department of Laboratory Medicine, Faculty of Health Sciences, Catholic University in Ružomberok, SK-03401 Ružomberok, Slovakia.
- Department of Pharmacology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, SK-03601 Martin, Slovakia.
ORCID-Profile: Daniela Mokra, Juraj Mokry
Förderung
- Slovak Research and Development Agency
- Ministry of Education, Science, Research and Sport of the Slovak Republic
Zitieren
APA
Mokra, D., Porvaznik, I., & Mokry, J. (2025). N-Acetylcysteine in the Treatment of Acute Lung Injury: Perspectives and Limitations. International Journal of Molecular Sciences, 26(6), 2657. https://doi.org/10.3390/ijms26062657
Vancouver
Mokra D, Porvaznik I, Mokry J. N-Acetylcysteine in the Treatment of Acute Lung Injury: Perspectives and Limitations. International Journal of Molecular Sciences. 2025;26(6):2657. doi:10.3390/ijms26062657
BibTeX
@article{Mokra2025,
author = {Mokra, Daniela and Porvaznik, Igor and Mokry, Juraj},
title = {N-Acetylcysteine in the Treatment of Acute Lung Injury: Perspectives and Limitations},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {6},
pages = {2657},
doi = {10.3390/ijms26062657}
}
EUVIMED